total (n = 146) | male (n = 58) | female (n = 88) | p value | |
---|---|---|---|---|
Age (year) | 37.09 ± 8.51 | 39.41 ± 8.65 | 35.56 ± 8.11 | 0.007 |
Median course of treatment (weeks) | 36 | 48 | 36 | 0.004 |
range | 12–96 | |||
Baseline HBsAg level (logIU/ml) | 2.87 ± 1.13 | 2.67 ± 1.12 | 3 ± 1.12 | 0.084 |
HBeAg positive (%) | 62 (42.5%) | 19 (32.8%) | 43 (48.9%) | 0.054 |
Baseline ALT (U/L) | 20 (14, 37) | 28.5 (17, 42.75) | 18 (13, 30.5) | 0.009 |
Baseline thyroid autoantibody positive | 29 | 12 | 17 |